Also listed on Pulmokine, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Oct 10, 2034 · High confidence
20-year base term ends Oct 10, 2034
Held by Gilead Sciences, Inc. and Pulmokine, Inc.
Filed Apr 8, 2016 as application 15/028,347 · Granted Mar 27, 2018
Base term, 20 years from filing
Today
2014
2034
Clock starts
Oct 10, 2014
Oct 10, 2014
Term ends
Oct 10, 2034
Oct 10, 2034
Granted
Mar 27, 2018
Mar 27, 2018
base term
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 10, 2014, when application PCT/US2014/060039, the earliest non-provisional in its chain, was filed (this one was filed Apr 8, 2016) | Oct 10, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 10, 2034 | High confidence |
This family
| Application PCT/US2014/060039 | PCT application no patent term | no patent term |
| US 9,925,184 | this patent Oct 2034 | Oct 2034 |
| Application 15/809,054 | Abandoned not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 19, 2016 Reel 39190, frame 805 | Zisman, Lawrence S. | Pulmokine, Inc. | Assignment of Assignor's Interest |
| Jun 27, 2017 reel/frame not recorded | Pulmokine, Inc. | Gilead Sciences, Inc. | Assignment of Assignor's Interest |
| Jun 27, 2017 reel/frame not recorded | Pulmokine, Inc. | Pulmokine, Inc. | Assignment of Assignor's Interest |
| Jun 27, 2017 Reel 42826, frame 411 | Pulmokine, Inc. | Gilead Sciences, Inc.; Pulmokine, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2034
Term ends Oct 10, 2034. Maintenance fees still fall due before then
Citations
19
later US patents cite this one
That is top 25% of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.